Retrospective Cohort Study
Copyright ©The Author(s) 2024.
World J Hepatol. Mar 27, 2024; 16(3): 379-392
Published online Mar 27, 2024. doi: 10.4254/wjh.v16.i3.379
Table 3 Transplant and intensive care outcomes comparison between fungal and bacterial cohorts
Characteristic
Bacteria, n = 1831
Fungal, n = 271
P value2
Intensive care outcomes
ACLF grade0.017
< 250 (36)2 (9.5)
≥ 290 (64)19 (90)
Death during admission or hospice95 (52)25 (93)< 0.001
Vasopressor requirement 129 (70)26 (96)0.004
Mechanical ventilation 118 (65)26 (96)< 0.001
Indication for intubation
Airway protection93 (79)22 (85)0.6
Respiratory failure25 (21)4 (15)
Dialysis due to acute kidney injury 95 (52)21 (78)0.014
ICU LOS (d)5 (2, 10)6 (4, 16)0.063
Hospital LOS (d)16 (7, 28)17 (12, 30)0.3
Hosp admit to ICU (d) 0 (0, 6)8 (0, 13)0.046
Transplant-related outcomes
Evaluated for transplant107 (58)13 (48)0.3
Listed57 (53)4 (31)0.13
Organ listed0.3
Liver44 (79)3 (60)
Liver and kidney12 (21)2 (40)
Hold placed32 (57)4 (100)0.14
Transplant occurred28 (50)0 (0)0.056